TOFACITINIB CITRATE vs XELJANZ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Attribute	TOFACITINIB CITRATE	XELJANZ
Rating	New	60/100
Pharmacy pays	~$65.78 /30	~$65.78 /30
Type	RX	RX
Active ingredient	TOFACITINIB CITRATE	TOFACITINIB CITRATE
Manufacturer	Somerset Theraps LLC	Pfizer
Dosage forms	Tablet, extended release	Solution, Tablet
Drug class	Janus Kinase Inhibitor	Janus Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Rheumatoid Arthritis	Rheumatoid Arthritis

tofacitinib citrate xeljanz

Rating

New

60/100

Pharmacy pays

~$65.78 /30

Type

Active ingredient

TOFACITINIB CITRATE

Manufacturer

Somerset Theraps LLC

Pfizer

Dosage forms

Tablet, extended release

Solution, Tablet

Drug class

Janus Kinase Inhibitor

Boxed warning

Treats

Rheumatoid Arthritis

Frequently asked questions

Which is cheaper, Tofacitinib Citrate or Xeljanz?

Pharmacies pay about the same to acquire either one — roughly $65.78 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Tofacitinib Citrate and Xeljanz?

Both Tofacitinib Citrate and Xeljanz share the active ingredient Tofacitinib Citrate.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.